CoChat

JNK and Tumor Necrosis Factor-α Mediate Free Fatty Acid-induced Insulin Resistance in 3T3-L1 Adipocytes

Open access

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Abstract

Lipid infusion and high fat feeding are established causes of systemic and adipose tissue insulin resistance. In this study, we treated 3T3-L1 adipocytes with a mixture of free fatty acids (FFAs) to investigate the molecular mechanisms underlying fat-induced insulin resistance. FFA treatment impaired insulin receptor-mediated signal transduction and decreased insulin-stimulated GLUT4 translocation and glucose transport. FFAs activated the stress/inflammatory kinases c-Jun N-terminal kinase (JNK) and IKKbeta, and the suppressor of cytokine signaling protein 3, increased secretion of the inflammatory cytokine tumor necrosis factor (TNF)-alpha, and decreased secretion of adiponectin into the medium. RNA interference-mediated down-regulation of JNK blocked JNK activation and prevented most of the FFA-induced defects in insulin action. Blockade of TNF-alpha signaling with neutralizing antibodies to TNF-alpha or its receptors or with a dominant negative TNF-alpha peptide had a partial effect to inhibit FFA-induced cellular insulin resistance. We found that JNK activation by FFAs was not inhibited by blocking TNF-alpha signaling, whereas the FFA-induced increase in TNF-alpha secretion was inhibited by RNA interference-mediated JNK knockdown. Together, these results indicate that 1) JNK can be activated by FFAs through TNF-alpha-independent mechanisms, 2) activated JNK is a major contributor to FFA-induced cellular insulin resistance, and 3) TNF-alpha is an autocrine/paracrine downstream effector of activated JNK that can also mediate insulin resistance.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m504611200

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIGURE 1 Effects of FFA treatment on intracellular signaling. Serum- and glucose-starved 3T3-L1 adipocytes were pretreated with 1 mM FFA for 1 h and stimulated with 1.7 nM insulin as indicated. Cell lysates were prepared and analyzed by SDS-PAGE and immunoblotting. The activated state of these signaling molecules was assessed using phosphotyrosine ( pY ) and phospho ( p )-specific antibodies. A , FFAs inhibit the IR signaling cascade by down-regulating the activation of key signaling intermediates IR 𝛃 , IRS-1, Akt, and PKC 𝛌 . B , FFAsactivatestressandinflammatorykinases.FFAtreatmentcausedthephosphorylationofJNKandIKK 𝛃 butnotIKK 𝛂 andthesubsequentphosphorylationoftheinhibitorofNF𝛋 B, I 𝛋 B 𝛂 . NS , nonspecific. Representative results from six independent experiments.
FIGURE 1 Effects of FFA treatment on intracellular signaling. Serum- and glucose-starved 3T3-L1 adipocytes were pretreated with 1 mM FFA for 1 h and stimulated with 1.7 nM insulin as indicated. Cell lysates were prepared and analyzed by SDS-PAGE and immunoblotting. The activated state of these signaling molecules was assessed using phosphotyrosine ( pY ) and phospho ( p )-specific antibodies. A , FFAs inhibit the IR signaling cascade by down-regulating the activation of key signaling intermediates IR 𝛃 , IRS-1, Akt, and PKC 𝛌 . B , FFAsactivatestressandinflammatorykinases.FFAtreatmentcausedthephosphorylationofJNKandIKK 𝛃 butnotIKK 𝛂 andthesubsequentphosphorylationoftheinhibitorofNF𝛋 B, I 𝛋 B 𝛂 . NS , nonspecific. Representative results from six independent experiments.CC-BY · From the PDF
FIGURE 2 Effects of FFA treatment on GLUT4 translocation and glucose transport. A , FFAs inhibit the insulin-stimulated translocation of the glucose transporter GLUT4 to the plasma membrane. 3T3-L1 adipocytes were electroporated with a dually tagged HA-GLUT4-GFP construct. Two days post-transfection, serum-starved cells were treated with ( H18554 ) or without ( f ) 500 𝛍 M FFA for 3 h and then stimulated with 170 nM insulin for 5, 10, 15, or 25 min. GLUT4 translocation kinetics were assayed and analyzed as described under 'Experimental Procedures.' The data are the average ± S.E. of four independent experiments (a total of 80-100 cells/time point). B , FFAs inhibit insulin-stimulated glucose uptake. Serum- and glucose-starved 3T3-L1 adipocytes were treated with 1 mM FFA for 1 h, 500 𝛍 MFFAfor3h,or300 𝛍 M for 6 h, prior to insulin stimulation (1.7 nM). 2-Deoxyglucose ( 2-DOG ) uptake was assayed as described under 'Experimental Procedures.' In recovery experiments, FFA-containing medium was removed, and 3T3-L1 adipocytes were fed with fresh medium. Glucose uptake was assessed 12 h later in the presence of insulin, as above. Glucose uptake was expressed relative to uptake levels found in untreated, unstimulated adipocytes ( white bars ). White bars , basal; light gray bars , insulin; dark gray bars , FFA; black bars , FFA + insulin; hatched bars , FFA washout + insulin. C , FFAs act upstream of PI 3-kinase and/or in a PI 3-kinase-independent pathway to inhibit glucose transport. 3T3-L1 adipocytes were infected with an adenovirus encoding a constitutively active form of the catalytic subunit of PI 3-kinase (p110 CAAX) or a control adenovirus 2 days prior to FFA treatment (1 mM, 1 h), and glucose uptake (1.7 nM insulin stimulation) was assayed as above. All bar graphs are representative of 4-6 independent experiments for each condition in quadruplicate. a.u. , arbitrary units.
FIGURE 2 Effects of FFA treatment on GLUT4 translocation and glucose transport. A , FFAs inhibit the insulin-stimulated translocation of the glucose transporter GLUT4 to the plasma membrane. 3T3-L1 adipocytes were electroporated with a dually tagged HA-GLUT4-GFP construct. Two days post-transfection, serum-starved cells were treated with ( H18554 ) or without ( f ) 500 𝛍 M FFA for 3 h and then stimulated with 170 nM insulin for 5, 10, 15, or 25 min. GLUT4 translocation kinetics were assayed and analyzed as described under 'Experimental Procedures.' The data are the average ± S.E. of four independent experiments (a total of 80-100 cells/time point). B , FFAs inhibit insulin-stimulated glucose uptake. Serum- and glucose-starved 3T3-L1 adipocytes were treated with 1 mM FFA for 1 h, 500 𝛍 MFFAfor3h,or300 𝛍 M for 6 h, prior to insulin stimulation (1.7 nM). 2-Deoxyglucose ( 2-DOG ) uptake was assayed as described under 'Experimental Procedures.' In recovery experiments, FFA-containing medium was removed, and 3T3-L1 adipocytes were fed with fresh medium. Glucose uptake was assessed 12 h later in the presence of insulin, as above. Glucose uptake was expressed relative to uptake levels found in untreated, unstimulated adipocytes ( white bars ). White bars , basal; light gray bars , insulin; dark gray bars , FFA; black bars , FFA + insulin; hatched bars , FFA washout + insulin. C , FFAs act upstream of PI 3-kinase and/or in a PI 3-kinase-independent pathway to inhibit glucose transport. 3T3-L1 adipocytes were infected with an adenovirus encoding a constitutively active form of the catalytic subunit of PI 3-kinase (p110 CAAX) or a control adenovirus 2 days prior to FFA treatment (1 mM, 1 h), and glucose uptake (1.7 nM insulin stimulation) was assayed as above. All bar graphs are representative of 4-6 independent experiments for each condition in quadruplicate. a.u. , arbitrary units.CC-BY · From the PDF
FIGURE 3 FFA treatment decreases adiponectin secretion. 3T3-L1 adipocytes were starved for 1 h prior to treatment with 1 mM FFA for 1 h and insulin stimulation (1.7 nM). Conditioned medium was then collected, and cells were lysed. Both media and lysates werefractionatedbySDS-PAGEandimmunoblottedusingapolyclonalantibodyagainst mouseadiponectin to determine the levels of secreted and intracellular adiponectin ( A ). B , relative levels of adiponectin released from adipocytes treated with FFAs, as assessed from four independent experiments. *, p < 0.05; a.u. , arbitrary units.
FIGURE 3 FFA treatment decreases adiponectin secretion. 3T3-L1 adipocytes were starved for 1 h prior to treatment with 1 mM FFA for 1 h and insulin stimulation (1.7 nM). Conditioned medium was then collected, and cells were lysed. Both media and lysates werefractionatedbySDS-PAGEandimmunoblottedusingapolyclonalantibodyagainst mouseadiponectin to determine the levels of secreted and intracellular adiponectin ( A ). B , relative levels of adiponectin released from adipocytes treated with FFAs, as assessed from four independent experiments. *, p < 0.05; a.u. , arbitrary units.CC-BY · From the PDF
FIGURE 5 Inhibition of FFA-induced JNK activation and insulin action. On day 7 postdifferentiation, 48 h after electroporation with JNK siRNA ( mJ2B ) or scrambled siRNA ( scr ), adipocytes were serum- and glucose-starved, treated with FFA (1 mM, 1 h) with or without insulin stimulation (17 nM, 20 min) and assayed for glucose uptake as above. Cell lysates were concurrently prepared for Western blotting analysis of components of the insulin signaling cascade. A , JNK knockdown rescues FFA-induced impairment in insulinstimulated glucose transport by ∼ 95-100% (*, p < 0.01). a.u., arbitrary units. Representative results from four independent experiments in triplicate are shown. B , inhibition of FFA-induced JNK activation ameliorates insulin signaling in FFA-treated adipocytes. The activated, phosphorylated states of IR 𝛃 and Akt were determined by Western blotting usingphosphotyrosine( pY ) and phosphospecific antibodies. JNK knockdownprevented the FFA-induced decrease in phosphorylated IR 𝛃 and Thr 308 - and Ser 473 -phosphorylatedAktproteins.Representativeresultsfromfourindependentexperimentsareshown.
FIGURE 5 Inhibition of FFA-induced JNK activation and insulin action. On day 7 postdifferentiation, 48 h after electroporation with JNK siRNA ( mJ2B ) or scrambled siRNA ( scr ), adipocytes were serum- and glucose-starved, treated with FFA (1 mM, 1 h) with or without insulin stimulation (17 nM, 20 min) and assayed for glucose uptake as above. Cell lysates were concurrently prepared for Western blotting analysis of components of the insulin signaling cascade. A , JNK knockdown rescues FFA-induced impairment in insulinstimulated glucose transport by ∼ 95-100% (*, p < 0.01). a.u., arbitrary units. Representative results from four independent experiments in triplicate are shown. B , inhibition of FFA-induced JNK activation ameliorates insulin signaling in FFA-treated adipocytes. The activated, phosphorylated states of IR 𝛃 and Akt were determined by Western blotting usingphosphotyrosine( pY ) and phosphospecific antibodies. JNK knockdownprevented the FFA-induced decrease in phosphorylated IR 𝛃 and Thr 308 - and Ser 473 -phosphorylatedAktproteins.Representativeresultsfromfourindependentexperimentsareshown.CC-BY · From the PDF
FIGURE 4 Inhibiting FFA-induced JNK activation. On day 5 postdifferentiation, 3T3-L1 adipocytes were electroporated with two independent JNK2 siRNAs (mJ2A and mJ2B). 48 h later, cells were treated with FFA (1 mM, 1 h), lysed, and subjected to SDS-PAGE and Western blot analysis using JNK and phospho-JNK antibodies. A , siRNAmediated knockdown of JNK2 reduced endogenous JNK2 protein levels by > 80%, without altering actin protein levels. B , siRNA-mediated knockdown of JNK2 markedly reduced FFA-induced activation of JNK as evaluated by phosphorylated JNK protein levels. Representative results from eight experiments are shown.
FIGURE 4 Inhibiting FFA-induced JNK activation. On day 5 postdifferentiation, 3T3-L1 adipocytes were electroporated with two independent JNK2 siRNAs (mJ2A and mJ2B). 48 h later, cells were treated with FFA (1 mM, 1 h), lysed, and subjected to SDS-PAGE and Western blot analysis using JNK and phospho-JNK antibodies. A , siRNAmediated knockdown of JNK2 reduced endogenous JNK2 protein levels by > 80%, without altering actin protein levels. B , siRNA-mediated knockdown of JNK2 markedly reduced FFA-induced activation of JNK as evaluated by phosphorylated JNK protein levels. Representative results from eight experiments are shown.CC-BY · From the PDF
FIGURE 6 FFAs increase the secretion of TNF𝛂 . Starved 3T3-L1 adipocytes were treated with 1 mM FFA for 1 h. Conditioned medium was collected and analyzed for TNF𝛂 content using an ELISA. Levels of secreted TNF𝛂 were expressed relative to basal TNF𝛂 levels from non-FFA-treated adipocytes. 12 samples were analyzed for each condition, and statistical significance was achieved ( p < 0.001).
FIGURE 6 FFAs increase the secretion of TNF𝛂 . Starved 3T3-L1 adipocytes were treated with 1 mM FFA for 1 h. Conditioned medium was collected and analyzed for TNF𝛂 content using an ELISA. Levels of secreted TNF𝛂 were expressed relative to basal TNF𝛂 levels from non-FFA-treated adipocytes. 12 samples were analyzed for each condition, and statistical significance was achieved ( p < 0.001).CC-BY · From the PDF
Image 7
CC-BY · From the PDF
FIGURE8 Effect of FFAs on SOCS-3protein. A , FFAs alter the protein expression pattern of SOCS-3, an effect that is not inhibited by blocking TNF𝛂 signaling. Serum-starved 3T3-L1 adipocytes were treated with 1 mM FFA for 1 h, with or without 1.7 nM insulin stimulation, with or without pretreatment with 2 𝛍 g/mlneutralizing antibodies to TNF𝛂 or control IgG. Cell lysates were prepared, fractionated by SDS-PAGE, and immunoblotted with polyclonal antibodies against SOCS-1 and SOCS-3 proteins. In control IgGtreated adipocytes, as in nonpretreated cells (data not shown), FFA treatment did not affect SOCS-1 protein expression. However, it altered the SOCS-3 protein expression pattern, increasing the expression of the high molecular weight form of SOCS-3. This effect was not blocked by pretreatment with TNF𝛂 -neutralizing antibodies ( lanes 5 and 6 versus lanes 1 and 2 ). Representative results from six experiments in duplicate are shown. B , adipocytes were electroporated with JNK2 siRNA ( mJ2B ) or scrambled siRNA ( scr ) 48 h prior to FFA treatment. The effect of FFA on SOCS-3 protein expression in these JNK-deficient cells was assessed as above. siRNA-mediated JNK knockdown markedly diminished the change in the SOCS-3 protein expression pattern induced by FFAs, including the increased levels of high molecular weight SOCS-3 protein. Representative results from four independent experiments are shown.
FIGURE8 Effect of FFAs on SOCS-3protein. A , FFAs alter the protein expression pattern of SOCS-3, an effect that is not inhibited by blocking TNF𝛂 signaling. Serum-starved 3T3-L1 adipocytes were treated with 1 mM FFA for 1 h, with or without 1.7 nM insulin stimulation, with or without pretreatment with 2 𝛍 g/mlneutralizing antibodies to TNF𝛂 or control IgG. Cell lysates were prepared, fractionated by SDS-PAGE, and immunoblotted with polyclonal antibodies against SOCS-1 and SOCS-3 proteins. In control IgGtreated adipocytes, as in nonpretreated cells (data not shown), FFA treatment did not affect SOCS-1 protein expression. However, it altered the SOCS-3 protein expression pattern, increasing the expression of the high molecular weight form of SOCS-3. This effect was not blocked by pretreatment with TNF𝛂 -neutralizing antibodies ( lanes 5 and 6 versus lanes 1 and 2 ). Representative results from six experiments in duplicate are shown. B , adipocytes were electroporated with JNK2 siRNA ( mJ2B ) or scrambled siRNA ( scr ) 48 h prior to FFA treatment. The effect of FFA on SOCS-3 protein expression in these JNK-deficient cells was assessed as above. siRNA-mediated JNK knockdown markedly diminished the change in the SOCS-3 protein expression pattern induced by FFAs, including the increased levels of high molecular weight SOCS-3 protein. Representative results from four independent experiments are shown.CC-BY · From the PDF
FIGURE 9 JNK lies upstream of TNF𝛂 in mediating the effects of FFAs on insulin action. A , blocking TNF𝛂 signaling does not inhibit FFA-induced JNK activation. 3T3-L1 adipocytes were treated with 1 mM FFA for 1 h, with or without pretreatment with 2 𝛍 g/ml neutralizing antibodies to TNF𝛂 or control IgG. Cell lysates were fractionated by SDS-PAGEandimmunoblottedwithpolyclonal antibodies against phospho-JNK. Representative results from four independent experiments are shown. B , blocking JNK activation does inhibit FFA-induced increase in TNF𝛂 secretion. Adipocytes were electroporated with JNK2 siRNA ( mJ2B ) 48 h prior to starvation and FFA treatment (1 mM, 1 h). TNF𝛂 content was quantified in conditioned medium by ELISA. Six samples were analyzed for each condition, and statistical significance was achieved ( p < 0.05). White bars , control; black bars , JNK2 siRNA.
FIGURE 9 JNK lies upstream of TNF𝛂 in mediating the effects of FFAs on insulin action. A , blocking TNF𝛂 signaling does not inhibit FFA-induced JNK activation. 3T3-L1 adipocytes were treated with 1 mM FFA for 1 h, with or without pretreatment with 2 𝛍 g/ml neutralizing antibodies to TNF𝛂 or control IgG. Cell lysates were fractionated by SDS-PAGEandimmunoblottedwithpolyclonal antibodies against phospho-JNK. Representative results from four independent experiments are shown. B , blocking JNK activation does inhibit FFA-induced increase in TNF𝛂 secretion. Adipocytes were electroporated with JNK2 siRNA ( mJ2B ) 48 h prior to starvation and FFA treatment (1 mM, 1 h). TNF𝛂 content was quantified in conditioned medium by ELISA. Six samples were analyzed for each condition, and statistical significance was achieved ( p < 0.05). White bars , control; black bars , JNK2 siRNA.CC-BY · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 47 references

Research works printed but not linked: 1

  1. Worrall, D. S., and Olefsky, J. M. (2002) Mol. Endocrinol. 16, 378 -389 · doi:10.1210/mend.16.2.0776 · Paper page

Cited by

Items 301–400 of 418

Metadata

Authors
Nguyen, M. T. A., Satoh, H., Favelyukis, S., Babendure, J. L., Imamura, T., Sbodio, J. I., Zalevsky, J., Dahiyat, B. I., Chi, N.-W., & Olefsky, J. M.
Affiliations
University of California San Diego (US)
Corresponding author
Olefsky, Jerrold M.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2005-10
Volume
280
Issue
42
Pages
35361-35371
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2122660225
Cited by
411
References
47
Citations by year
2026: 3 · 2025: 9 · 2024: 10 · 2023: 6 · 2022: 8 · 2021: 10 · 2020: 16 · 2019: 21 · 2018: 12 · 2017: 20 · 2016: 17 · 2015: 23 · 2014: 32 · 2013: 26 · 2012: 15
FWCI
20.67
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK-33651)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
Keywords
insulin resistance, free fatty acids, c-Jun N-terminal kinase, TNF-α, 3T3-L1 adipocytes, insulin receptor signaling, GLUT4 translocation, glucose transport, IKKβ, SOCS3, adiponectin, TNF signaling, autocrine and paracrine signaling, high-fat feeding
MeSH terms
Suppressor of Cytokine Signaling 3 Protein, Animals, Biological Transport, Cell Differentiation, Deoxyglucose, Enzyme Activation, Enzyme-Linked Immunosorbent Assay, Fatty Acids, Nonesterified, Genes, Dominant, Glucose, Inflammation, Insulin, Insulin Resistance, Lipids, Time Factors, Tumor Necrosis Factor-alpha, Blotting, Western, Signal Transduction, Down-Regulation, Adipocytes, Protein Transport, RNA Interference, 3T3-L1 Cells, JNK Mitogen-Activated Protein Kinases, MAP Kinase Kinase 4, Suppressor of Cytokine Signaling Proteins, Glucose Transporter Type 4, Mice, I-kappa B Kinase, Adiponectin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.